Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia.

Charpentier A, Lebreton A, Rauch A, Bauters A, Trillot N, Nibourel O, Tintillier V, Wemeau M, Demory JL, Preudhomme C, Jude B, Lecompte T, Cambier N, Susen S.

Haematologica. 2016 Sep;101(9):e365-8. doi: 10.3324/haematol.2016.144279. Epub 2016 May 31. No abstract available.

2.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

3.

[DVT and combined oral contraceptives: update of the pluridisciplinary CNGOF-FNCGM-GEHT-SFMV group].

Chabbert-Buffet N, Guigues B, Trillot N, Biron C, Morange P, Pernod G, Scheffler M, Brugere S, Hedon B.

J Gynecol Obstet Biol Reprod (Paris). 2013 Jun;42(4):309-15. doi: 10.1016/j.jgyn.2013.03.015. Epub 2013 May 1. Review. French.

4.

Inferior vena cava agenesis and deep vein thrombosis: 10 patients and review of the literature.

Lambert M, Marboeuf P, Midulla M, Trillot N, Beregi JP, Mounier-Vehier C, Hatron PY, Jude B.

Vasc Med. 2010 Dec;15(6):451-9. doi: 10.1177/1358863X10391355. Review.

PMID:
21183652
5.

[Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?].

Lambert M, Trillot N, Cooren G, Glantenet R, Jude B, Hatron PY.

J Mal Vasc. 2010 Dec;35(6):348-51. doi: 10.1016/j.jmv.2010.08.004. French.

PMID:
20888159
6.

[When to test for thrombophilia?].

Pernod G, Biron-Andreani C, Morange PE, Boehlen F, Constans J, Couturaud F, Drouet L, Jude B, Lecompte T, Le Gal G, Trillot N, Wahl D.

Rev Prat. 2009 Oct 20;59(8):1044-6. French. No abstract available.

PMID:
19894436
7.

Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.

Picard V, Chen JM, Tardy B, Aillaud MF, Boiteux-Vergnes C, Dreyfus M, Emmerich J, Lavenu-Bombled C, Nowak-Göttl U, Trillot N, Aiach M, Alhenc-Gelas M.

Hum Genet. 2010 Jan;127(1):45-53. doi: 10.1007/s00439-009-0742-6. Epub 2009 Sep 17.

PMID:
19760264
8.

Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline.

Pernod G, Biron-Andreani C, Morange PE, Boehlen F, Constans J, Couturaud F, Drouet L, Jude B, Lecompte T, Le Gal G, Trillot N, Wahl D; French group on haemostasis and thrombosis; French Society of vascular medicine.

J Mal Vasc. 2009 May;34(3):156-203. English, French. No abstract available.

PMID:
19645086
9.

Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Circulation. 2007 Feb 20;115(7):840-5.

PMID:
17309934
10.

Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.

Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group.

J Thromb Haemost. 2006 Jun;4(6):1259-65.

11.

Post-operative use of heparin increases morbidity of pacemaker implantation.

Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Jabourek O, Trillot N, Lacroix D, Kacet S.

Europace. 2006 Apr;8(4):283-7. Epub 2006 Mar 16.

PMID:
16627455
12.

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.

Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Circulation. 2005 Nov 29;112(22):3495-500. Epub 2005 Nov 21.

PMID:
16301339
13.

Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.

Deruelle P, Denervaud M, Hachulla E, Ducloy-Bouthors AS, Valat AS, Puech F, Trillot N, Hatron PY, Subtil D.

Eur J Obstet Gynecol Reprod Biol. 2006 Jul;127(1):73-8. Epub 2005 Oct 20.

PMID:
16242833
14.

[Polycythemia vera and pregnancy: difficulties for diagnosis and treatment].

Deruelle P, Bouhassoun J, Trillot N, Jude B, Ducloy AS, Subtil D.

Gynecol Obstet Fertil. 2005 May;33(5):331-7. Epub 2005 Apr 18. French.

PMID:
15878688
15.

[Hormone replacement therapy and venous thromboembolism].

Trillot N, Susen S, Jude B.

Gynecol Obstet Fertil. 2004 Sep;32(9):725-8. Review. French.

PMID:
15380753
16.

[Risk factors of thromboembolism associated with pregnancy and the puerperium. Role of inherited and acquired thrombophilia].

Ducloy-Bouthors AS, Trillot N.

Ann Med Interne (Paris). 2003 Sep-Oct;154(5-6):295-300. Review. French.

PMID:
15027582
17.

Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.

Poon MC, d'Oiron R, Hann I, Négrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kühne A, Petrini P, Fressinaud E, Morfini M, Tengborn L, Marquès-Verdier A, Musso R, Devecioglu O, Houston DS, Lethagen S, Van Geet C, von Depka M, Berger C, Beurrier P, Britton HA, Gerrits W, Guthner C, Kuhle S, Lorenzo JJ, Makris PE, Nohe N, Paugy P, Pautard B, Torchet MF, Trillot N, Vicariot M, Wilde J, Winter M, Chambost H, Ingerslev J, Peters M, Strauss G.

Semin Hematol. 2001 Oct;38(4 Suppl 12):21-5. Review.

PMID:
11735106
18.

Preclinical phase of polycythemia vera in pregnancy.

Subtil D, Deruelle P, Trillot N, Jude B.

Obstet Gynecol. 2001 Nov;98(5 Pt 2):945-7.

PMID:
11704215
19.
20.

[What vascular events suggest a myeloproliferative disorder?].

Hachulla E, Rose C, Trillot N, Caulier-Leleu MT, Pasturel-Michon U.

J Mal Vasc. 2000 Dec;25(5):382-387. Review. French.

PMID:
11148402
21.

[G20210A transition in the prothrombin gene and venous thromboembolic disease].

Trillot N, Zawadzki C, Watel A, Jude B.

Rev Med Interne. 2000 Oct;21(10):911-4. Review. French.

PMID:
11075405
22.

[Constitutional thrombophilias: indications of the biological profile and therapeutic consequences].

Trillot N, Rugeri L, Jude B.

Therapie. 1999 Jul Aug;54(4):413-8. Review. French.

PMID:
10667107
23.

Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family.

Zawadzki C, Gaveriaux V, Trillot N, Bauters A, Watel A, Alhenc-Gelas M, Preudhomme C, Jude B.

Thromb Haemost. 1998 Dec;80(6):1027-8. No abstract available.

PMID:
9869179
24.

[Is the thermolabile variant of methylenetetrahydrofolate reductase a risk factor of arterial and venous thrombosis?].

Trillot N, Jude B.

Rev Med Interne. 1997;18 Suppl 6:657s-659s. Review. French. No abstract available.

PMID:
9515147
25.

Two cases of t(1;16)(p11;p11) in multiple myeloma: confirmation by chromosome painting.

Flactif M, Laï JL, Zandecki M, Bernardi F, Trillot N, Bauters F, Facon T.

Cancer Genet Cytogenet. 1994 Aug;76(1):10-4.

PMID:
8076342

Supplemental Content

Loading ...
Support Center